WuXi Biologics CEO expects approval for Covid-19 antibody treatment 'late this year or early next year'

WuXi Biologics has signed more than 10 deals with clients to research antibodies that can potentially deliver treatment for the coronavirus.

from Health and Science https://ift.tt/2Hi4QII
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH